Mislabeled fentanyl patches recalled

Alvogen, a pharmaceutical company based in New Jersey, is recalling two lots of its transdermal fentanyl patches due to faulty product labeling.

Advertisement

The affected lots of Fentanyl Transdermal System 12 mcg/h transdermal patches were distributed to pharmacies.

Alvogen said a small number of cartons labeled as containing 12 mcg/h patches actually contain 50 mcg/h patches, which are individually labeled as having the 50 mcg/h dose.

3M Drug Delivery Systems manufacturers the product, which helps manage pain in opioid-tolerant patients.

More articles on supply chain:
FDA braces for medical device shortages: 9 things to know
Reports of breast implant ‘illness’ spur FDA safety review
5 supply chain technologies to watch

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.